Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Miracles for Mya Hosts Second Annual Gala in March to Support Children Battling Cancer

Miracles for Mya

Miracles for Mya, a beacon of hope for families facing pediatric cancer, is thrilled to announce its Second Annual Miracles for Mya Gala on March 8, 2025. The event will celebrate the organization's remarkable impact, including providing over $56,000 in holiday gifts to children battling cancer in 2024. It will also raise crucial funds to continue its mission of delivering joy and support to children with cancer and their families. “Building on the success of last year’s inaugural gala, this year's event promises an unforgettable evening filled with entertainment, raffles, and an opportunity to make a difference, said Misti Alberico Tinajero, President of Miracles for Mya. “All proceeds from the gala will directly benefit Miracles for Mya and our ability to help bring tiny miracles for the families and children battling pediatric cancer.” The gala, priced at $85 per person, offers guests not only a night of dinner, dancing, and an open bar but also entertainment by renowned Chicago DJ Eddie V. Guests will also have the opportunity to participate in raffles for prizes that include a $1000 Southwest Airlines Gift Card, a PlayStation 5, and a Go Kart. “The Miracles for Mya Gala is not just a fundraiser; it's a powerful opportunity to raise awareness about pediatric cancer and highlight the profound impact kindness and compassion can have on families in their most challenging moments,” said Antonio Tinajero, Vice President of Miracles for Mya. “The Miracles for Mya Gala is not just a fundraiser; it’s a celebration of resilience, hope, and the power of community.” Miracles for Mya Gala When: Saturday, March 8, 2025 5:00 PM Where: Tuscany Falls Banquets 9425 W 191st St Mokena, IL 60448, USA Tickets: Purchase here. Since its founding in 2018, Miracles for Mya has donated over 9,000 toys to children at local area hospitals throughout Northeastern Illinois. The 2024 holiday season was one of the busiest yet, with the nonprofit reaching a significant milestone—providing over $56,000 in gifts to children facing the brave battle against cancer. Over $160,000 in toys and financial aid has been distributed by the charity in the last seven years. About Mya: Started by Mya’s Parents, Miracles for Mya is a 501(c)(3) nonprofit organization founded after Mya's courageous battle with stage IV Neuroblastoma. Mya was a typical 4-year-old who loved pink, princesses, and all things Disney. Mya’s (and her family’s) life changed on January 11, 2011, when they heard the words “Mya has cancer.” Mya was diagnosed with stage IV Neuroblastoma and was high-risk from the beginning. As scary as cancer was, nothing was going to change who this kid was. She was always known for her smile, kindness, generosity, and bravery. Mya fought long and hard over the next 6 years, never once believing that she couldn’t conquer cancer. Throughout her years, Mya left a lasting impression on all whom she encountered. Learn more at miraclesformya.org. To learn more about Miracles for Mya and the charityâs work, visit miraclesformya.org. Miracles for Mya is a 501(c)(3) nonprofit organization, and all proceeds are tax deductible. Contact Details Raynor Ave. Aaron Alberico +1 202-744-0786 aalberico@raynoravenue.com Company Website https://miraclesformya.org/

February 19, 2025 08:00 AM Eastern Standard Time

Image

NAVEX One: The Trusted Partner for NIS2 Risk Alignment

NAVEX Global

NAVEX, the global leader in integrated risk and compliance management software, is pleased to offer the first GRC solution to holistically address NIS2 across training, policies and assessment – all on one platform, NAVEX One. NAVEX continues to provide risk and compliance professionals with the tools they need to align with the latest cybersecurity regulations. As organizations face increasing regulatory demands, NAVEX One integrates policy management, training and risk assessment resources to ensure seamless compliance with the European Union’s Network and Information Security Directive (NIS2). The NIS2 Directive raises the bar for cybersecurity and reporting standards across industries, including banking, healthcare, manufacturing and energy. Organizations must not only comply with these heightened regulations but also ensure their cybersecurity frameworks are strong enough to withstand evolving threats. “NIS2 is a critical milestone in cybersecurity regulation, and organizations need a partner that helps them do more than just check the compliance box,” said A.G. Lambert, chief product officer at NAVEX. “NAVEX One empowers compliance and risk professionals to build a sustainable and proactive approach to cybersecurity, ensuring their programs are compliant and resilient against emerging threats.” NAVEX One serves as an essential tool in the journey toward risk and compliance maturity, helping organizations: Conduct proactive risk assessments to identify and mitigate vulnerabilities Centralize and streamline policy management to meet regulatory expectations Strengthen cybersecurity posture with comprehensive security awareness training Stay ahead of evolving cybersecurity requirements through continuous program improvement and board-ready reporting Extend training, policies and cyber risk practices to align third parties with its cyber risk standards “Organizations today require more than just static risk and compliance checklists—they need dynamic, integrated solutions that evolve with regulatory changes and emerging risks,” said Kyle Martin, vice president of risk solutions at NAVEX. “NAVEX One’s content and capabilities give businesses the confidence to proactively address NIS2 requirements while reinforcing their broader risk management strategies.” By integrating these capabilities within a single platform, NAVEX One simplifies compliance, reduces risk exposure, and supports organizations in building future-proof compliance programs. Click here, for more information on NAVEX One and the NIS2 Directive. NAVEX is trusted by thousands of customers worldwide to help them achieve the business outcomes that matter most. As the global leader in integrated risk and compliance management software and services, we deliver solutions through the NAVEX One platform, the industry’s most comprehensive governance, risk and compliance (GRC) information system. For more information, visit NAVEX.com and our blog. Follow us on Twitter and LinkedIn. Contact Details Navex Global scott.levesque@navex.com Company Website https://navex.com

February 18, 2025 12:50 PM Eastern Standard Time

Lifesaving Communication: A Free Vital Roundtable on Emergency Response Language Services

American Translators Association

Español | Français | Tiếng Việt In critical moments when lives are on the line, clear and immediate communication can mean the difference between chaos and resolution. The American Translators Association (ATA) invites professionals across emergency response, crisis management, law enforcement, the media, health care, education, and the language services industry to a groundbreaking event: Best Practices in Emergency Response Language Services. This event is already drawing nationwide attention. Considering the recent onslaught of global crises such as floods, wildfires, epidemics, terrorism, mass shootings, airline crashes, and beyond, the majority of us at home, work, or play may need to respond to an unexpected crisis at any time. Three Essential Perspectives, One Transformative Discussion This 90-minute, high-impact event approaches emergency response language services from three unique but interconnected vantage points: Providers of emergency language and communications services – the trained professionals delivering real-time interpreting, translation, and general communication assistance during high-stakes situations. Recipients of these services – individuals and communities relying on linguists to navigate crisis and emergency situations. Essential players bridging the gap – first responders, law enforcement, dispatchers, teachers, and even astronauts who depend on linguists and other professional communicators for seamless, lifesaving connection. Meet the Experts Shaping the Future of Emergency Language Access Our distinguished panel brings together professionals who have stood on the front lines of crisis communication: Rhode Thomas, a seasoned interpreter and cultural mediator who interpreted on the ground during Hurricane Helene as well as for the National Center for School Crisis and Bereavement after a school shooting, will share firsthand insights on bridging language barriers in emergency medical, legal, and social service settings. Aaron Kubey, a FEMA employee and certified Deaf Interpreter, will discuss how accessibility measures are transforming disaster response, including real-world applications of ASL in crisis situations. Sergeant Clarence E. Stokes III, a 32-year veteran of the Pennsylvania Capitol Police and active shooter instructor, will explore crisis response tactics and how language professionals can assist in high-risk law enforcement encounters. Anh Pham, an interpreter for President Obama during his 2016 Vietnam visit, will discuss the intense preparation and political stakes involved in high-profile, international language services. Marjorie "Ocho" Kouns, a multilingual enhanced 911 (e911) Dispatcher in Atlanta, will reveal the challenges behind emergency calls and the urgency of accurate communication in 911 dispatch. Chantal Kamgne, an expert in localization and community language equity, will discuss the impact of cultural awareness in emergency translations and crisis communication. Liliana Trujillo, a bilingual medical professional, will speak to the critical need for linguistically and culturally sensitive communication in patient care and emergency health scenarios. Moderated by Bridget Hylak, CT, CI, MTC, a globally recognized language industry expert and communications strategist. Key Discussion Points: What are the fundamental factors that ensure effective language access in emergency response services? How can first responders, law enforcement, educators, health care providers, and the media collaborate with linguists and other professional communicators to improve accuracy and efficiency in crisis communication? What role does cultural sensitivity play in building trust and ensuring compliance with diverse communities? How do professional interpreters and translators handle high-pressure situations —such as natural disasters, active shooter incidents, or international crises—while maintaining composure and clarity? When is technology a help or a hindrance in emergency translation and interpreting? A Rare Opportunity to Learn, Prepare, and Connect Panelists will not focus solely on AI or language technology, though emerging tools will be addressed. Instead, this roundtable will tap into the depth of each participant’s experience, highlighting the techniques, connection, demeanor, preparation, composure, and human expertise it takes to handle these life-or-death situations well, regardless of the methods used. Attendees will leave with actionable insights on: Best practices for emergency language services in law enforcement, medical, educational, and corporate disaster response - and beyond. Practical strategies for handling high-pressure, high-stakes encounters with confidence. Regulatory and ethical considerations in high-stakes response scenarios. This nationally relevant event is a must-attend for anyone involved in emergency response, crisis communication, and language services. Register now at ATA’s Event Registration Page to secure your spot. For media inquiries or further information, contact: Jamie Hartz ATA Public Relations Committee Chair pr-chair@atanet.org ATA is a professional association founded in 1959 to advance the translation and interpreting professions and foster the professional development of translators and interpreters. With thousands of members in more than 100 countries, the Association includes translators, interpreters, language services providers, educators, project managers, localization specialists, hospitals, universities, and government agencies. Contact Details American Translators Association Jamie Hartz, Public Relations Committee Chair pr-chair@atanet.org Company Website https://www.atanet.org/

February 13, 2025 10:30 AM Eastern Standard Time

Image

Flash Appoints Chris Donus CEO

Flash

Flash, the leader in parking and mobility technology, today announced that Chris Donus, currently the President of Flash, has been appointed Chief Executive Officer. Donus joined Flash as CFO in 2023 and became President in June 2024. Dan Sharplin, who has served as Flash CEO since 2019, will continue as Executive Chairman of the Board of Directors. "It’s the perfect moment for Chris to step into the CEO role and lead Flash in its next phase of growth," said Dan Sharplin, Executive Chairman, Flash. "Chris is a proven leader, and as those who’ve worked with him will attest, has the ability to drive execution at speed and at scale that promises to take Flash to new heights." Sharplin will shift focus to strategy and Board leadership, actively supporting Chris Donus and the executive team and steering strategic projects and partnerships. He will continue advancing Flash’s industry leadership and driving its vision for the digital transformation of the industry to a modern marketplace that delivers seamless experiences to drivers and increased value and transparency for owners and operators. Donus will assume responsibility for strategic execution and continue leading the expansion of Flash’s emerging digital demand network, EV charging and parking platforms, and its regionalized branch organization. Donus joined Flash as a seasoned mobility and technology leader in finance and operations. Prior to Flash, he served as COO and CFO at Wheel Health, VP and Business Unit leader of Express Drive at Lyft, and served in President, COO and CFO roles at Silvercar. "I thank Dan Sharplin and the Board of Directors for their support and confidence as well as the incredible opportunity to lead the world class team we've assembled at Flash," said Donus. "I couldn't be more excited for the possibilities that lay ahead – for Flash and for the industry – as we continue the journey to make the transformation of parking a reality." An innovator in parking management technology since 2011, Flash has achieved unprecedented scale encompassing over 16,000 parking assets, 1 billion annual transactions, and 450 million driver touchpoints in the apps consumers use everyday. Flash is leading the industry transformation to a connected mobility ecosystem that delivers a seamless parking experience for drivers and unlocks profitability and asset yield for operators and owners. About Flash Flash is a pioneering technology company bringing seamless parking and EV charging experiences to drivers through a first-of-its-kind digital ecosystem. Flash’s platform connects reservable parking and charging in the apps drivers use every day with garage, surface lot, event, and valet parking locations — connected and controlled via a cloud-based operating system with unrivaled intelligence. Customer-obsessed brands partner with Flash to deliver digital, easy-to-use, reliable, and increasingly frictionless experiences to drivers eager to pay for a solution that eliminates wasted time, excess emissions, and stress from driving. The solution has arrived. Visit www.flashparking.com to learn more. Contact Details Ray Young +1 512-694-6097 ray@razorsharppr.com Company Website https://www.flashparking.com/

February 13, 2025 08:15 AM Central Standard Time

Mothers’ Milk Bank California Welcomes Dr. Spieler as New Medical Advisor

The Mothers' Milk Bank

Mothers’ Milk Bank California announced today the appointment of Dr. Lauren Spieler, an Osteopathic Physician Board Certified in Family Medicine and Breastfeeding Medicine, as the organization’s new Medical Advisor. Dr. Spieler brings extensive expertise in breastfeeding and postpartum care to the team. Dr. Spieler practices Family Medicine and Breastfeeding Medicine at Kaiser Permanente in Santa Rosa, California, where she has established a Breastfeeding Medicine Clinic. As the Kaiser Permanente Regional Lactation Lead, she focuses on improving lactation services across Northern California. Dr. Spieler also serves as Medical Director for the Sonoma County Breastfeeding Coalition, leading initiatives to support breastfeeding families in the region. Dr. Spieler is dedicated to elevating postpartum and 4th trimester care and is a strong advocate for the mission of the San Jose Donor Milk Bank. She will contribute her knowledge and expertise as the organization continues to expand and improve its services. “We are thrilled to welcome Dr. Spieler to our team. Her extensive experience and strong commitment to advancing breastfeeding and postpartum care will significantly strengthen our efforts to support families in California and beyond,” said Jennifer Benito-Kowalski, CEO for Mothers’ Milk Bank California. “We are excited to see our programs grow and improve with her leadership.” For more information about Dr. Spieler or Mothers’ Milk Bank California, please contact Andrea Racelis, Communications Manager at (408) 111-2222 or Andrea.Racelis@MothersMilk.org Founded 50 years ago, Mothers' Milk Bank California is a leading nonprofit dedicated to providing screened, donated human milk to babies in need. As a founding member of the Human Milk Banking Association of North America (HMBANA), it helped set standards for nonprofit milk banks across North America. The organization collects, pasteurizes, and distributes safe human milk to hospitals and families, ensuring essential nutrition for infants. Committed to improving lives, Mother's Milk Bank California supports families and advances neonatal care. Contact Details Mothers Milk Bank California Andrea Racelis +1 408-638-2874 andrea.racelis@mothersmilk.org Company Website https://mothersmilk.org/

February 11, 2025 12:00 PM Pacific Standard Time

Image

AI In Healthcare Matters: How LogicMark Leverages AI In Its Advanced Monitoring Devices

Benzinga

By Meg Flippin Benzinga Artificial intelligence has permeated every aspect of our lives, from how we bank to how we consume entertainment. It’s also playing an increasing role in healthcare, helping doctors, hospitals and healthcare facilities improve care while cutting costs. It’s not surprising AI is finding its way into healthcare. The global healthcare market is huge, projected to hit $44.76 billion by 2032, growing at a CAGR of 9% between now and 2032. But it’s also a market with a lot of inefficiencies that AI can play a role in improving, from enhancing care to assisting doctors and nurses in diagnosis and treatment. With remote monitoring, AI holds the promise of reducing costs and ensuring ongoing care. Not to mention AI can do a lot of the heavy lifting on the administrative front, freeing up caregivers to focus on care. AI Already Assisting The Medical Community As it stands, AI is already helping doctors make more accurate diagnoses, improve and assist in treatment planning, enable early detection of diseases and ailments, better manage and protect patient data and improve patient care in and out of the hospital. Take medical imaging, for starters. AI algorithms can quickly analyze X-rays, CT scans and MRIs, helping doctors spot diseases and tumors with greater speed and accuracy. AI is also being used to accelerate drug development and enable virtual assistants and chatbots, taking telemedicine to the next level. But AI’s role doesn’t end there. It is also playing a big role in medical and monitoring devices that help people live independent lives. That’s particularly important as our population ages. Older adults want to live more independently, and medical and monitoring devices are an important part of achieving that goal. AI collects and analyzes data from the monitoring device in real-time, looking for anomalies in patterns that could signal something is amiss and potentially save a life. How LogicMark’s AI-Powered Devices Can Save Lives That’s particularly true of the AI-driven devices LogicMark Inc. (NASDAQ: LGMK) is producing. The maker of personal emergency response systems (PERS ), health communications devices and Internet of Things technologies is no stranger to AI, incorporating it into two of its popular monitoring devices – the Freedom Alert Max and the Freedom Alert Mini. Both are designed to empower people to live independently on the go and at home and rely on AI to make it happen. Take the AI-driven fall detection technology that is integral to both of these devices. LogicMark’s built-in fall detection technology senses when someone has fallen and sends an alert to an emergency monitoring center, a loved one or 911. It can prove life-saving if a user falls and can’t dial an emergency contact due to an injury they’ve sustained or because they’ve become unconscious or disoriented. This is an extremely important feature – unintentional falls are the leading cause of death among Americans aged 65 and older. LogicMark reports its AI will continue to learn and be updated to ensure it evolves to meet the needs of the user. Hand-in-hand with fall detection are the company’s GPS location services which can pinpoint where the user fell and alert authorities. The devices connect to a 24/7 monitoring service that promptly contacts first responders, loved ones or caregivers when necessary. All of that is possible thanks to LogicMark embracing AI. Check out LogicMark’s investment deck here. LogicMark Turns Mobile Phones Into Safety Devices Then there’s LogicMark’s Aster app that turns mobile phones into personal safety devices. With a tap or slide of the screen, help can be on the way in minutes. Loved ones can track you until you reach your destination, automatically call for help if you don’t check in on the app after a scheduled meeting or appointment and send emergency services to your exact location thanks to GPS tracking. The companion Bluetooth button, which is free when you sign up for Aster, is a small device that clips to a purse, keychain or backpack strap that users can push to call for help without opening their phone. The button calls for help with three presses, and a 24/7 monitoring service will answer and stay on the phone until users feel safe. But it doesn’t end there. The company is on a mission to empower people of all ages to lead lives with dignity and independence and is on a path to create a connected care platform that brings together software apps, health communication devices, services and technology, all driven by AI. It’s not surprising the executive team at LogicMark is made up of leaders with years of experience and patents in AI and the Internet of Things. That gives them the insight necessary to develop smart monitoring devices that protect people at home or on the go. AI is playing a major role in healthcare, helping doctors make better diagnoses and hospitals cut costs. It’s also improving care and giving people freedom and independence. LogicMark is focused on taking this market to the next level and is relying on AI for an assist. Take a glance at LogicMark’s stock information here. Featured photo by Google DeepMind on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 10, 2025 08:45 AM Eastern Standard Time

Image

CONSENSUS HEALTH NAMES CHRISTINE HAYEK CHIEF OPERATING OFFICER

Consensus Health

Consensus Health, a leading New Jersey-based healthcare organization with a physician-led medical group and an Independent Physician Alliance (IPA), announced today the appointment of Christine Hayek to the post of chief operating officer. Hayek brings more than 25 years of healthcare operational experience to her new role. As COO, Hayek will be responsible for working closely with Consensus Health’s growing network of 172 independent providers currently and their teams to improve each respective practice’s performance and leverage the collective impact on the overall medical group. Before receiving her promotion to COO, Hayek held the role of vice president of operations and human resources for more than two years. In this capacity, she oversaw day-to day-operations and performance of Consensus Health’s then 57 physician practices throughout New Jersey. She led new practice acquisitions, provider recruitment and related onboarding and talent management. Prior to joining Consensus Health, Hayek spent nearly 20 years at AtlantiCare Health System, the largest healthcare organization in Southern New Jersey. During her tenure, she was responsible for leading design and implementation of multiple initiatives to improve access, enhance provider and patient experience, and drive financial performance of the medical group and health system. She served in various key roles of increasing responsibility across both healthcare operations and human resources. On the operations side, she was executive director of physician practice operations, corporate director of population health transformation and assistant vice president of transformation. In the HR realm, she served as director of benefits. During her two decades at AlantiCare, she oversaw numerous strategic growth initiatives, including: redesign of employee health programs that resulted in introduction of the first self-funded health plan within its accountable care organization; acquisition and integration of more than 30 physician practices; and, unveiling of 20 new medical locations. “Christine’s appointment is well-deserved; she is a leader with a proven track record in driving success and growth by partnering with providers and their respective teams to improve patient experience, elevate engagement and ensure both physician satisfaction as well as productivity. We look forward to the contributions she will make in this new role and the skills she brings to our leadership team as she helps guide Consensus Health on our path to continued success,” stated Michael Lovett, Consensus Health chief executive officer. Lovett previously served as Consensus Health’s chief operating officer for nearly three years before being named chief executive officer in early 2024. Hayek assumes this role left vacant by Lovett’s promotion and will report directly to him. Hayek, a resident of Galloway, New Jersey, holds a bachelor’s degree in business management from Slippery Rock University in Slippery Rock, Pennsylvania. as well as a master’s degree in business administration from Stockton University in Galloway, New Jersey. About Consensus Health Marlton, New Jersey-based Consensus Health is a leading physician-owned and -governed medical group comprised of New Jersey-based independent primary care providers and specialty doctors. Consensus Health affords its 172 member providers across 56 practices and 69 locations clinical autonomy, which enables them to focus on the delivery of high levels of patient care within the local markets they each serve. Currently, Consensus Health provides medical care statewide throughout 18 New Jersey counties. For more information, visit www.consensushealth.com or connect with the Company on LinkedIn. Contact Details PAIRELATIONS for Consensus Health Susan J. Turkell +1 303-766-4343 sturkell@pairelations.com Company Website https://www.consensushealth.com/

February 10, 2025 08:00 AM Eastern Standard Time

Image

SBC Medical (NASDAQ: SBC) Announces New Translation App After Zacks & Sidoti Initiate Coverage, Emphasize Strong Growth

Benzinga

By Gerelyn Terzo, Benzinga With a potential Goldilocks setup in the economy being encouraged in part by a resilient consumer, the broader stock market was hovering near record territory toward the end of last year. Not to be outdone, healthcare-related companies have also been rallying, as evidenced by a gain of almost 20% in the S&P 500 Health Care Sector Index over the past 12 months. One of the stocks that has captured the attention of Wall Street of late is Tokyo-based SBC Medical Group (NASDAQ: SBC), a fast-growing service provider in the burgeoning medical aesthetics market that trades on Nasdaq. Most recently, Zacks Small-Cap Research (SCR) and Sidoti & Company have initiated coverage on the stock. In the October report, Zacks emphasized SBC Medical Group’s expansion efforts comprising both mergers and acquisitions, and organic growth, owing to a growing franchisee network and revenue base buttressed by a strong balance sheet. SBC Medical has been an early mover in Japan’s aesthetic medicine market, which according to the analyst firm, serves as a tailwind for future growth. Zacks SCR believes SBC Medical has “significant value.” Investors who are looking to back a leader in the medical innovation space can learn more about the opportunity in SBC Medical stock here. SBC Medical’s Growing Revenue Chief among the catalysts for the outlook in the report is SBC Medical’s strong reported revenue growth. The company’s revenue has been growing year-over-year, increasing from $174 million in 2022 to $194 million in 2023. Total revenues for the nine months ending Sep. 30, 2024 were $160 million, representing an increase of 23% from $131 million in the same period of 2023, SBC said. As a franchisor, SBC Medical has been growing its footprint amid a rising number of clinics in its vast network that contribute royalty revenue. In addition to Japan, the company also operates clinics in Los Angeles and Ho Chi Minh City, Vietnam, and has set its sights on a global expansion. SBC Medical is also operating in the black, reporting that with net income for the nine months ending Sep. 30, 2024 of $40.1 million, compared to $24.3 million in the same period of 2023. The company’s performance is being fueled by rising royalty income and other revenue streams with high gross margins, it says. Capitalizing On Medical Tourism For New Revenue Opportunities In 2025 The company has announced numerous initiatives to enhance its revenue streams in order to continue to grow its business both domestically and internationally. In January, SBC announced the launch of its proprietary translation app tailored for medical aesthetics staff and the full-scale implementation of its Inbound-Focused Clinics initiative. SBC says this move is designed to address the growing demand for medical tourism and to ensure that international patients can seamlessly experience Japan's advanced medical aesthetic treatments. Within Asia, rising awareness of aesthetic care and the increasing appeal of medical tourism are positioning countries like Japan, South Korea, and Thailand as top destinations for international patients, SBC notes. In Japan, the influx of foreign patients seeking high-quality medical aesthetics continues to rise. SBC alone says it welcomes over 10,000 inbound patients annually, with inquiries surpassing 20,000 each year. China remains a key market driver, though demand from English-speaking regions is also on the rise, the company says. Recognizing this trend, SBC says it is scaling up its operational capacity and implementing innovative solutions to support sustainable growth in this dynamic sector. Striving To Shift Communication With A Specialized Translation App To address language barriers, SBC has developed a translation app tailored specifically for medical aesthetics. It says the app ensures the accurate translation of specialized terminology, facilitating seamless communication between clinic staff and international patients. Currently supporting English and Chinese, the app plays a pivotal role in enabling smooth consultations and pre-treatment explanations. By creating a welcoming environment where language is no obstacle, SBC says it is empowering patients to feel secure and confident in their treatment choices. Future plans include expanding the app's language capabilities and rolling it out across all clinics nationwide, ensuring comprehensive accessibility for a global clientele, SBC noted. SBC Medical’s Valuation: Opportunities And Risks Zacks SCR pointed out that the medical aesthetic market is one that lacks direct competitors despite some companies offering similar services to SBC Medical. As a result, it is difficult to make apples-to-apples comparisons on the stock valuation as analysts typically do. In response, the Zacks analyst has taken a subset of the medical aesthetics space specializing in the healthcare sector to determine a fair valuation. The estimate is contingent upon the company executing on its growth plans as well as a broadening of its initiatives. Zacks SCR is encouraged by SBC Medical’s engagement with the industry, as evidenced by its participation in the Aesthetic Surgery and Laser Society (ASLS) aesthetic medicine conference in Korea held earlier this year. The firm also mentioned SBC Medical’s recently inked partnership with Tokyo-based technology provider B4A, which provides high-tech business solutions. SBC Medical’s mettle was tested amid a business combination with Pono Capital Two, a deal that was completed in Septemb er 2024, paving the way for the stock’s debut on Nasdaq. When it comes to investing, there are no sure things. Zacks SCR and Sidoti have also outlined potential risks that investors might consider. Among them is the uncertain nature of the wider aesthetic medical industry, which is heavily dependent on emerging technology for its growth. SBC’s international presence presents a foreign exchange risk since Its businesses are transacted in Japanese yen but translated into U.S. dollars for reporting purposes, a dynamic that has affected the company’s year-to-date financial performance in 2024. Investors who believe that the benefits outweigh the risks in SBC Medical’s stock can dive deeper into some of the company’s latest developments and offerings here. Featured photo by nattanan23 on Pixabay Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 07, 2025 08:35 AM Eastern Standard Time

Image

Cognition Therapeutics Presents Phase 2 Results For Drug To Fight DLB At International Conference

Benzinga

By Meg Flippin, Benzinga Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders including dementia with Lewy bodies (DLB), had the opportunity to raise awareness about its experimental drug zervimesine (CT1812) when the company presented trial results in a podium presentation at the International Lewy Body Dementia Conference (ILBDC). The eighth International Lewy Body Dementia Conference, held in Amsterdam last week, drew an international audience of advocates, scientists and physicians looking for ways to fight this debilitating disease. Zervimesine is an experimental, orally delivered small molecule oligomer antagonist designed to treat this progressive form of dementia. Cognition Therapeutics recently reported positive topline results of its exploratory phase 2 SHIMMER study for the drug, announcing zervimesine produced strong therapeutic responses across behavioral, functional, cognitive and movement measures in patients with DLB. “Older adults with DLB are often placed in care facilities not because of memory issues, but due to the severity of neuropsychiatric or motor symptoms that overwhelm their caregivers,” said James E. Galvin, MD, MPH, director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine, who was the study director for SHIMMER. “Patients on zervimesine had fewer cognitive fluctuations and showed better motor control than placebo-treated patients. The results from this exploratory phase 2 trial demonstrated zervimesine could have a meaningful, positive impact on DLB patients across multiple measures of cognitive, behavioral, movement and functional performance, potentially enabling people with DLB to live at home with the assistance of their care partners.” DLB Drug Holds Promise DLB is a progressive form of dementia characterized by symptoms that fluctuate in severity and can be difficult to diagnose early. It can cause people to have hallucinations, delusions and anxiety as well as cognitive declines that impair their thinking and reasoning. It can cause uncontrollable changes in alertness, sleep disruptions, tremors and slow movement. DLB impacts about 1.4 million people in the U.S. and is the costliest form of dementia. The double-blind, placebo-controlled phase 2 SHIMMER study had 130 adults enrolled who were evenly divided into groups that received either a placebo or a daily dose of zervimesine for six months. Cognition Therapeutics reported the study met its primary endpoint of safety and tolerability. As presented at ILBDC, zervimesine-treated DLB patients scored an average of 86% better than placebo-treated patients on the neuropsychiatric inventory (NPI) A-L at the end of the study. This tool describes the frequency and severity of 12 separate behavioral symptoms. The impact on the NPI scale in the SHIMMER trial means that patients receiving zervimesine had fewer or less severe hallucinations and delusions and less anxiety and agitation than placebo-treated patients, the company noted. These symptoms are a hallmark of DLB and can be debilitating for patients. The improvement in these behavioral symptoms was measured not only for patients but also their care partners, who reported improvements in their levels of distress caused by these symptoms. Patients, Caregivers Benefit From Zervimesine Patients who received zervimesine also preserved 52% more of their ability to care for themselves, measured by the activities of daily living (ADCS-ADL) scale, compared to those taking the placebo. Cognition said this was likely due to the improvements in behavioral symptoms as well as a 91% reduction in cognitive fluctuations in zervimesine-treated patients. Cognitive fluctuations are another hallmark of DLB and are described as a non-responsive state that can occur suddenly and last for hours. The person experiencing the fluctuation may or may not be aware that it is happening. On top of all that, the company said that based on trial results, zervimesine treatment allowed patients to maintain 62% better motor function – including gait, balance and tremors – than those on the placebo. “Dr. Galvin’s presentation is an important opportunity to educate an international audience of advocates, scientists and physicians about the impressive efficacy signals that were observed in participants treated with zervimesine (CT1812),” said Anthony O. Caggiano, MD, PhD, Cognition’s CMO and head of R&D. “The improvement we observed across behavioral, cognitive, functional and motor symptoms in zervimesine-treated participants suggest a broad and meaningful impact on their daily lives. These results reinforce zervimesine’s potential to address the complex and debilitating symptoms of this disease.” Featured photo by Pawel Czerwinski on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 06, 2025 09:00 AM Eastern Standard Time

Image

1 2 3 4 5 ... 312